Prognostic value of preoperative platelet-related parameters and plasma fibrinogen in patients with non-muscle invasive bladder cancer after transurethral resection of bladder tumor.

Aim: To investigate the prognostic value of preoperative mean platelet volume (MPV), MPV/lymphocyte ratio (MPVLR), MPV/platelet count ratio and plasma fibrinogen in patients with non-muscle invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT). Methods: A total of 371 patients who underwent TURBT were enrolled. The main end points were disease-free survival (DFS) and overall survival (OS). Results: MPVLR, tumor size, tumor number and pathological grade were independent risk factors for postoperative DFS. Age and pathological grade were independent risk factors for postoperative OS. Conclusion: MPVLR is an independent risk factor for DFS in NMIBC patients and could be used as a parameter to predict postoperative tumor recurrence in patients after TURBT.

• Publication year

  2022

• Venue

  Future Oncology

• Publication date

  2022-07-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/fon-2022-0223PMID 35880441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy.

  2021cited by this paper
• Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy

  2021cited by this paper
• The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study

  2021cited by this paper
• Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.

  2021cited by this paper
• Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy

  2020cited by this paper
• Preoperative Survival Prediction in Patients With Glioblastoma by Routine Inflammatory Laboratory Parameters

  2020cited by this paper
• Treatment of muscle‐invasive and advanced bladder cancer in 2020

  2020cited by this paper
• Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis

  2020cited by this paper
• Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita.

  2020cited by this paper
• Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer

  2020cited by this paper
• The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer

  2019cited by this paper
• Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma

  2019cited by this paper
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2018cited by this paper
• Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke

  2018cited by this paper
• Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.

  2018cited by this paper
• Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?

  2018cited by this paper
• Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.

  2018cited by this paper
• Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO

  2017cited by this paper
• Platelet distribution width correlates with prognosis of non-small cell lung cancer

  2017cited by this paper
• Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer

  2017cited by this paper
• EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

  2017cited by this paper
• Inflammation, Immunity, and Cancer

  2017cited by this paper
• Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer

  2017cited by this paper
• The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.

  2016cited by this paper
• Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.

  2015cited by this paper
• Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer.

  2015cited by this paper
• Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.

  2014cited by this paper
• The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.

  2011cited by this paper

• Mean platelet volume to lymphocyte ratio as an inflammatory marker associated with high-grade recurrence and progression of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin

  2024cites this paper
• Prognostic role of dynamic changes in inflammatory indicators in patients with non-small cell lung cancer treated with immune checkpoint inhibitors—a retrospective cohort study

  2024cites this paper
• The prognostic value of preoperative plasma fibrinogen in Asian patients with urothelial cancer: a systematic review and meta-analysis

  2024cites this paper
• Impact of clinical factors on accuracy of ovarian cancer detection via platelet RNA profiling

  2024cites this paper
• The use of platelets as a clinical tool in oncology: opportunities and challenges.

  2024cites this paper
• A novel platelet risk score for stratifing the tumor immunophenotypes, treatment responses and prognosis in bladder carcinoma: results from real-world cohorts

  2023cites this paper
• Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab

  2023cites this paper
• Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer

  2023cites this paper